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Abstract
Despite several advantages to bringing couples together to learn how to protect themselves and 
new-born children from the risk of HIV infection, most interventions are designed for individuals 
or groups, not for dyads. This meta-analysis provides a direct test of whether couple-based 
interventions are more effective in promoting HIV protective behaviors than interventions 
delivered to individuals. We conducted systematic searches of five electronic databases and 60 
journals. Eligible studies were controlled trials or prospective cohort designs; evaluated a couple-
based intervention compared to an individual-level intervention; assessed at least one HIV 
prevention outcome (e.g., protective sex, drug use, HIV testing, medication adherence, and 
sexually transmitted infections [STI]); and were published between 1988 and 2014. Fifteen 
interventions, including 21,882 participants from China, Kenya, Rwanda, Tanzania, Trinidad, 
Zambia, and the USA, were evaluated. The results of random-effects models showed statistically 
significant intervention effects for protective sex (OR = 1.60, 95% CI = 1.21, 2.11), HIV testing 
(OR = 1.79, 95% CI = 1.31, 2.45), and Nevirapine uptake (OR = 1.51, 95% CI = 1.02, 2.24). The 
evidence demonstrates the usefulness of couple-based interventions in protecting individuals, 
partners, and new-born children from the risk of HIV transmission and infection.
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INTRODUCTION
Sexual transmission of HIV continues to be the driving force of the epidemic in many parts 
of the world (UNAIDS, 2013). While a large proportion of HIV transmission takes place 
between two sexually intimate people, prevention efforts for heterosexuals, men who have 
sex with men (MSM), and people who use drugs have primarily focused on individuals or 
groups and typically have not included both members of a dyad (Jiwatram-Negron & El-
Bassel, 2014; Meader et al., 2013; Purcell et al., 2014). There are several advantages to 
bringing couples together to learn how to protect themselves from HIV and other sexually 
transmitted infections (STIs) (El-Bassel & Wechsberg, 2012; Jiwatram-Negron & El-Bassel, 
2014). It gives the couple the opportunity to learn and practice communication and 
negotiation skills together, facilitate disclosure of HIV serostatus and previous and current 
sexual risk and drug use behaviors in a safe environment, and foster a joint responsibility for 
preventing HIV and STI.
Additionally, couple-based voluntary HIV counseling and testing provides a shared 
knowledge base that, together with confirmation of serostatus, allows a couple to plan and 
make essential life decisions jointly about HIV treatment and reproductive health care 
(Jiwatram-Negron & El-Bassel, 2014). Acquiring partner’s support also facilitates adherence 
to HIV treatment (Langebeek et al., 2014; Sandelowski, Voils, Chang, & Lee, 2009). In the 
case of intimate couples becoming parents, involving fathers and incorporating their support 
in couple-based prevention of mother to child transmission may increase HIV testing among 
pregnant women and the uptake and adherence to Nevirapine among those who are tested 
positive for HIV (Kiarie, Kreiss, Richardson, & John-Stewart, 2003). Couple-based 
interventions have the potential for protecting not only individuals and partners, but also 
new-born children from the risk of HIV transmission and infection.
While a few published systematic reviews have evaluated couple-based interventions 
(Burton, Darbes, &Operario, 2010; Kennedy, Medley, Sweat, & O’Reilly, 2010; LaCroix, 
Pellowski, Lennon, & Johnson, 2013), none has directly tested whether couple-based 
interventions are more effective than interventions delivered to individuals in a relationship 
(referred to as individual-level interventions in this paper). In this systematic review and 
meta-analysis, we examine the effects of couple-based interventions that have been 
evaluated against individual-level interventions through experimental or cohort studies and 
provide estimates of the magnitude of couple-based intervention effects on HIV protective 
behaviors.
METHODS
Two content expert librarians conducted systematic, automated, and manual searches to 
locate relevant HIV intervention evaluation studies with behavioral or biologic outcomes. 
The automated searches consisted of five databases (and platforms): MEDLINE (OVID), 
EMBASE (OVID), PsycINFO (OVID), and CINAHL (EBSCOhost) and Sociological 
Abstracts (ProQuest). Two separate comprehensive searches were conducted: one for 
locating citations related to HIV/STI risk reduction and the other for locating citations 
related to HIV treatment and medication adherence. The full search strategy, including terms 
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and key words, used for searching MEDLINE and other databases for each of the two 
comprehensive searches are available from the corresponding author. The manual search 
consisted of searching 60 journals to identify potentially relevant citations not yet indexed in 
electronic databases at the time when the comprehensive searches were conducted.
Studies were eligible if they were controlled trials or prospective cohort designs, evaluated a 
couple-based, HIV-prevention intervention with an individual-level comparison group, 
assessed at least one HIV prevention outcome (e.g., sex or drug use behavior, STI, HIV 
testing, HIV treatment uptake, and medication adherence), reported data sufficient for 
calculating effect sizes, and were published between January 1988 and December 2014.
Before abstracting data, we searched for linked citations that are supplementary publications 
offering additional information on the same study. Pairs of trained coders independently 
coded each eligible study (with linked citations) using standardized coding forms for study 
characteristics, participant characteristics, interventions, and outcomes. There was 95% 
agreement between coders across variables. Coding discrepancies were reconciled by coding 
pairs. We contacted the primary study investigator to obtain additional information as 
needed and the response rate was 85%.
Odds Ratios (OR) and corresponding variances were calculated to estimate effect sizes 
(Lipsey & Wilson, 2001). The magnitude of heterogeneity of the effect sizes was tested 
using the Q statistic and I2 statistic (Higgins, Thompson, Deeks, & Altman, 2003). The 
Windsorizing method was applied to adjust any extreme effect size that was three standard 
errors from the mean of all effect sizes (Lipsey & Wilson, 2001). Weighted effect sizes were 
combined using a random-effects model (Hedges & Vevea, 1998). Sensitivity tests were 
conducted by removing one study at a time to determine if any study affected the aggregated 
point estimate. An OR > 1 indicates a greater odds of protective behavior in the couple-
based intervention relative to the individual-level comparison.
RESULTS
Figure 1 shows the flow of study selection. After screening titles, abstracts and full reports, 
15 couple-based interventions, including 21,882 participants, met the inclusion criteria 
(Figure 1). As seen in Table 1, study locations included China, Kenya, Rwanda, Tanzania, 
Trinidad, Zambia, and the United States. All studies except two exclusively focused on 
heterosexual couples. Two studies were specifically designed for HIV-serodiscordant 
couples. Eight studies were randomized controlled trials.
As reported in Table 2, outcomes examined include protective sex behavior (defined as 
consistent condom use or no sex without condoms), STIs, HIV testing, Nevirapine uptake 
among pregnant women, and HIV medication adherence. No studies evaluated drug use 
behaviors. The results of random-effect models showed statistically significant intervention 
effects for protective sex (OR = 1.60, 95% CI = 1.21, 2.11, p = 0.0012, nine effect sizes), 
HIV testing (OR = 1.79, 95% CI = 1.31, 2.45, p = .0000, three effect sizes), and Nevirapine 
uptake (OR = 1.51, 95% CI = 1.02, 2.24, p =0.0397, six effect sizes). There was insufficient 
evidence for STI and HIV medication adherence due to a small number of studies (only two 
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studies examining STI and one study on HIV medication adherence). Modest heterogeneity 
(i.e., I2 around 50%) was observed. One study included in the HIV testing outcome was 
windsorized (Semrau et al., 2005) and there was no evidence that any other individual effect 
size exerted influence on the aggregated effect sizes.
DISCUSSION
Our systematic review and meta-analysis provides direct evidence that couple-based 
interventions are more effective in promoting protective sex, HIV testing and Nevirapine 
uptake when directly compared to interventions delivered to individuals. The evidence 
demonstrates the usefulness of couple-based interventions in protecting individuals, 
partners, and newborn children from the risk of HIV transmission and infection.
Our findings are particularly important in the era of treatment as prevention. Couples HIV 
counseling and testing allows both members of a couple to learn their HIV status and make 
informed choices surrounding antiretroviral prophylaxis during pregnancy (for heterosexual 
couples) and antiretroviral therapy (ART). ART reduces HIV-1 infection within discordant 
couples (Baggaley, White, Hollingsworth, & Boily, 2013; Cohen et al., 2011); however, the 
non-zero transmission risk from partners receiving ART points to the need of appropriate 
counseling and risk-reduction strategies for discordant couples (Baggaley et al., 2013). 
Couple-based interventions can provide a supportive environment that enables a couple to 
disclose more safely to each other about personal and potentially difficult information (e.g., 
outside partners, STIs), to make a joint decision and responsibility for safer sex practice, and 
to capitalize partner’s support for prevention and care. Given the promise of couple-based 
interventions (Jiwatram-Negron & El-Bassel, 2014; Purcell et al., 2014), it is exciting that 
several treatment-as-prevention and preexposure prophylaxis (PrEP) trials have incorporated 
the couple-based component as part of biomedical interventions (Cohen et al., 2011; Baeten 
et al., 2012).
Several limitations warrant comment. The evidence presented is primarily driven by 
behavior changes among heterosexual couples. Only one study (Sullivan et al., 2014) that 
compared the couple-based intervention with an intervention delivered to individuals was 
specifically designed for MSM couples. Additionally, none of the included studies targeted 
drug users or evaluated drug use behaviors and only one study evaluated medication 
adherence outcomes. The findings should be reassessed when additional data become 
available. The U.S.-based studies primarily focused on sexual risk reduction, while most of 
the international studies focused on couple HIV testing or prevention of mother-to-child 
transmission. Replicating and adapting effective couple-based interventions in the countries 
where the interventions were not previously tested will be an important quest.
Based on the current couple-based research literature, several important operational 
questions merit future examinations: (1) Which intervention modalities work best and under 
what circumstances? and (2) What are the best strategies to combine couple-based 
interventions with other behavioral, structural and biomedical interventions in a scalable and 
cost-effective way? Although additional operational research is needed, couple-based 
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interventions can be utilized to enhance prevention effects and reduce HIV transmission and 
infection in the era of treatment as prevention.
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Figure 1. 
Study Selection
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